Skip to Content

Join the 'Rebif' group to help and get support from people like you.

Rebif News

FDA-OK'd Ocrevus Offers Hope to Sickest MS Patients

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – A new multiple sclerosis drug approved by the U.S. Food and Drug Administration late Tuesday offers hope to patients with the most severe form of the progressive disease. The intravenous drug, made by Genentech, is called ocrelizumab (Ocrevus). Given every six months, it worked best for patients with relapsing multiple sclerosis (MS) – the most common form of the ...

New MS Drug Yields Mixed Results in Study

Posted 7 Oct 2015 by Drugs.com

WEDNESDAY, Oct. 7, 2015 – Multiple sclerosis patients taking a new drug experienced fewer relapse rates but more side effects than patients receiving a standard MS therapy, new research indicates. In a trial comparing two sets of more than 900 patients with relapsing-remitting multiple sclerosis, scientists found that those taking the drug daclizumab HYP had a 45 percent lower relapse rate than ...

Rare, But Serious, Side Effect Reported With One MS Drug

Posted 2 Apr 2014 by Drugs.com

WEDNESDAY, April 2, 2014 – A handful of people taking a medication called Rebif to treat multiple sclerosis have developed a serious condition that causes blood clots to form in small blood vessels throughout the body. In a letter in the March 27 issue of the New England Journal of Medicine, Scottish researchers reported that they found an unexpectedly high number of cases of "thrombotic ...

Neurology Group Lists Procedures That May Be Unneeded

Posted 8 Mar 2013 by Drugs.com

FRIDAY, March 8 – Five tests, procedures and treatments that neurologists and their patients should question are outlined in a list released by the American Academy of Neurology (AAN) as part of the Choosing Wisely campaign. "With one in six people affected by a brain disease, such as headache, multiple sclerosis and stroke, our goal is to have patients discuss our Choosing Wisely ...

Drug Widely Used to Treat MS May Not Slow Progression

Posted 17 Jul 2012 by Drugs.com

TUESDAY, July 17 – Interferon beta, a widely used treatment for multiple sclerosis, does not stave off the time to disability, new research finds. However, prior studies have found that interferon beta does reduce MS flare ups, so patients should continue taking it, researchers said. The new study is published in the July 18 issue of the Journal of the American Medical Association. In multiple ...

Early Use of MS Drug May Cut Likelihood of Progression

Posted 19 Apr 2012 by Drugs.com

THURSDAY, April 19 – A new three-year study finds that a multiple sclerosis drug is more likely to prevent patients from progressing to a definite form of MS if it's given early in patients who appear to be ill. The drug, a form of interferon called "interferon beta-1a," is not available in the United States. It is, however, available in countries in the European Union, Canada and elsewhere. ...

Autoinjector Version of MS Drug Approved

Posted 28 Feb 2012 by Drugs.com

TUESDAY, Feb. 28 – A pen-delivery version of the multiple sclerosis drug Avonex has been approved by the U.S. Food and Drug Administration, drug manufacturer Biogen Idec said Tuesday. The self-administering Avonex autoinjector pen is designed to lessen pain and anxiety associated with MS, the Associated Press reported. The drug was first approved in 1996. On Tuesday, the FDA also approved new ...

Ask a Question

Further Information

Related Condition Support Groups

Multiple Sclerosis

Rebif Patient Information at Drugs.com